SLC30A1 and benign prostatic hyperplasia: Hasumi et al [39] reported that ZnT-1 expression was significantly lower in malignant prostate tissue samples when compared to BPH samples, which led them to conclude that ZnT-1 was not likely to be associated with the decreased zinc accumulation in the malignant cells.